Champions Oncology Awarded $2 Million NCI Grant to Develop, Study Prostate Cancer Models

Champions Oncology Awarded $2 Million NCI Grant to Develop, Study Prostate Cancer Models
Champions Oncology has signed a $2 million competitive contract through the National Cancer Institute’s (NCI) Small Business Innovation Research (SBIR) program to build and study metastatic prostate cancer models derived from ethnically diverse patients. Fully characterized, ethnically diverse prostate cancer patient-derived xenograft (PDX) models are underrepresented among PDX banks, limiting opportunities for preclinical and translational

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *